O'nyong-nyong fever in south-central Uganda, 1996-1997: clinical features and validation of a clinical case definition for surveillance purposes.

O'nyong-nyong (ONN) fever, caused by infection with a mosquito-borne central African alphavirus, is an acute, nonfatal illness characterized by polyarthralgia. During 1996-1997, south-central Uganda experienced the second ONN fever epidemic ever recognized. Among 391 persons interviewed and sam...

Full description

Bibliographic Details
Main Authors: Kiwanuka, N, Sanders, E, Rwaguma, E, Kawamata, J, Ssengooba, F, Najjemba, R, Were, W, Lamunu, M, Bagambisa, G, Burkot, T, Dunster, L, Lutwama, J, Martin, D, Cropp, C, Karabatsos, N, Lanciotti, R, Tsai, T, Campbell, G
Format: Journal article
Language:English
Published: 1999
_version_ 1797100941724352512
author Kiwanuka, N
Sanders, E
Rwaguma, E
Kawamata, J
Ssengooba, F
Najjemba, R
Were, W
Lamunu, M
Bagambisa, G
Burkot, T
Dunster, L
Lutwama, J
Martin, D
Cropp, C
Karabatsos, N
Lanciotti, R
Tsai, T
Campbell, G
author_facet Kiwanuka, N
Sanders, E
Rwaguma, E
Kawamata, J
Ssengooba, F
Najjemba, R
Were, W
Lamunu, M
Bagambisa, G
Burkot, T
Dunster, L
Lutwama, J
Martin, D
Cropp, C
Karabatsos, N
Lanciotti, R
Tsai, T
Campbell, G
author_sort Kiwanuka, N
collection OXFORD
description O'nyong-nyong (ONN) fever, caused by infection with a mosquito-borne central African alphavirus, is an acute, nonfatal illness characterized by polyarthralgia. During 1996-1997, south-central Uganda experienced the second ONN fever epidemic ever recognized. Among 391 persons interviewed and sampled, 40 cases of confirmed and 21 of presumptive, well-characterized acute, recent, or previous ONN fever were identified through active case-finding efforts or during a household serosurvey and by the application of clinical and laboratory criteria. Among confirmed cases, the knees and ankles were the joints most commonly affected. The median duration of arthralgia was 6 days (range, 2-21 days) and of immobilization was 4 days (range, 1-14 days). In the majority, generalized skin rash was reported, and nearly half had lymphadenopathy, mainly of the cervical region. Viremia was documented in 16 cases, primarily during the first 3 days of illness, and in some of these, body temperature was normal. During this epidemic, the combination of fever, arthralgia, and lymphadenopathy had a specificity of 83% and a sensitivity of 61% in the identification of cases of ONN fever and thus could be useful for surveillance purposes.
first_indexed 2024-03-07T05:44:52Z
format Journal article
id oxford-uuid:e6e294f0-0f81-4f2c-9206-778597d86e5e
institution University of Oxford
language English
last_indexed 2024-03-07T05:44:52Z
publishDate 1999
record_format dspace
spelling oxford-uuid:e6e294f0-0f81-4f2c-9206-778597d86e5e2022-03-27T10:34:12ZO'nyong-nyong fever in south-central Uganda, 1996-1997: clinical features and validation of a clinical case definition for surveillance purposes.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:e6e294f0-0f81-4f2c-9206-778597d86e5eEnglishSymplectic Elements at Oxford1999Kiwanuka, NSanders, ERwaguma, EKawamata, JSsengooba, FNajjemba, RWere, WLamunu, MBagambisa, GBurkot, TDunster, LLutwama, JMartin, DCropp, CKarabatsos, NLanciotti, RTsai, TCampbell, GO'nyong-nyong (ONN) fever, caused by infection with a mosquito-borne central African alphavirus, is an acute, nonfatal illness characterized by polyarthralgia. During 1996-1997, south-central Uganda experienced the second ONN fever epidemic ever recognized. Among 391 persons interviewed and sampled, 40 cases of confirmed and 21 of presumptive, well-characterized acute, recent, or previous ONN fever were identified through active case-finding efforts or during a household serosurvey and by the application of clinical and laboratory criteria. Among confirmed cases, the knees and ankles were the joints most commonly affected. The median duration of arthralgia was 6 days (range, 2-21 days) and of immobilization was 4 days (range, 1-14 days). In the majority, generalized skin rash was reported, and nearly half had lymphadenopathy, mainly of the cervical region. Viremia was documented in 16 cases, primarily during the first 3 days of illness, and in some of these, body temperature was normal. During this epidemic, the combination of fever, arthralgia, and lymphadenopathy had a specificity of 83% and a sensitivity of 61% in the identification of cases of ONN fever and thus could be useful for surveillance purposes.
spellingShingle Kiwanuka, N
Sanders, E
Rwaguma, E
Kawamata, J
Ssengooba, F
Najjemba, R
Were, W
Lamunu, M
Bagambisa, G
Burkot, T
Dunster, L
Lutwama, J
Martin, D
Cropp, C
Karabatsos, N
Lanciotti, R
Tsai, T
Campbell, G
O'nyong-nyong fever in south-central Uganda, 1996-1997: clinical features and validation of a clinical case definition for surveillance purposes.
title O'nyong-nyong fever in south-central Uganda, 1996-1997: clinical features and validation of a clinical case definition for surveillance purposes.
title_full O'nyong-nyong fever in south-central Uganda, 1996-1997: clinical features and validation of a clinical case definition for surveillance purposes.
title_fullStr O'nyong-nyong fever in south-central Uganda, 1996-1997: clinical features and validation of a clinical case definition for surveillance purposes.
title_full_unstemmed O'nyong-nyong fever in south-central Uganda, 1996-1997: clinical features and validation of a clinical case definition for surveillance purposes.
title_short O'nyong-nyong fever in south-central Uganda, 1996-1997: clinical features and validation of a clinical case definition for surveillance purposes.
title_sort o nyong nyong fever in south central uganda 1996 1997 clinical features and validation of a clinical case definition for surveillance purposes
work_keys_str_mv AT kiwanukan onyongnyongfeverinsouthcentraluganda19961997clinicalfeaturesandvalidationofaclinicalcasedefinitionforsurveillancepurposes
AT sanderse onyongnyongfeverinsouthcentraluganda19961997clinicalfeaturesandvalidationofaclinicalcasedefinitionforsurveillancepurposes
AT rwagumae onyongnyongfeverinsouthcentraluganda19961997clinicalfeaturesandvalidationofaclinicalcasedefinitionforsurveillancepurposes
AT kawamataj onyongnyongfeverinsouthcentraluganda19961997clinicalfeaturesandvalidationofaclinicalcasedefinitionforsurveillancepurposes
AT ssengoobaf onyongnyongfeverinsouthcentraluganda19961997clinicalfeaturesandvalidationofaclinicalcasedefinitionforsurveillancepurposes
AT najjembar onyongnyongfeverinsouthcentraluganda19961997clinicalfeaturesandvalidationofaclinicalcasedefinitionforsurveillancepurposes
AT werew onyongnyongfeverinsouthcentraluganda19961997clinicalfeaturesandvalidationofaclinicalcasedefinitionforsurveillancepurposes
AT lamunum onyongnyongfeverinsouthcentraluganda19961997clinicalfeaturesandvalidationofaclinicalcasedefinitionforsurveillancepurposes
AT bagambisag onyongnyongfeverinsouthcentraluganda19961997clinicalfeaturesandvalidationofaclinicalcasedefinitionforsurveillancepurposes
AT burkott onyongnyongfeverinsouthcentraluganda19961997clinicalfeaturesandvalidationofaclinicalcasedefinitionforsurveillancepurposes
AT dunsterl onyongnyongfeverinsouthcentraluganda19961997clinicalfeaturesandvalidationofaclinicalcasedefinitionforsurveillancepurposes
AT lutwamaj onyongnyongfeverinsouthcentraluganda19961997clinicalfeaturesandvalidationofaclinicalcasedefinitionforsurveillancepurposes
AT martind onyongnyongfeverinsouthcentraluganda19961997clinicalfeaturesandvalidationofaclinicalcasedefinitionforsurveillancepurposes
AT croppc onyongnyongfeverinsouthcentraluganda19961997clinicalfeaturesandvalidationofaclinicalcasedefinitionforsurveillancepurposes
AT karabatsosn onyongnyongfeverinsouthcentraluganda19961997clinicalfeaturesandvalidationofaclinicalcasedefinitionforsurveillancepurposes
AT lanciottir onyongnyongfeverinsouthcentraluganda19961997clinicalfeaturesandvalidationofaclinicalcasedefinitionforsurveillancepurposes
AT tsait onyongnyongfeverinsouthcentraluganda19961997clinicalfeaturesandvalidationofaclinicalcasedefinitionforsurveillancepurposes
AT campbellg onyongnyongfeverinsouthcentraluganda19961997clinicalfeaturesandvalidationofaclinicalcasedefinitionforsurveillancepurposes